Medical Frontiers

25.8. 22:30

NHK WORLD-JAPAN

30 minutes

While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30% of patients. We interview Japanese researchers who are trying to overcome this challenge.

More information

Record

About show

English

While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30% of patients. We interview Japanese researchers who are trying to overcome this challenge.